Prof. Davor Zeljezic, PhD, ERT works as a Scientific Advisor, tenure position, at the Institute for Medical Research and Occupational Health, Unit for Toxicology, Zagreb, Croatia. For last 25 years main field of his research has been genetic toxicology, methods applied being chromosomal aberrations analysis, micronucleus assay, alkaline and enzyme-modified comet assay, sister chromatid exchange test, fluorescent in situ hybridization (FISH) on metaphase chromosomes, micronucleus and comet assay. Beside genotoxicity evaluation in different cell culture models or animals determining the effect in different organs and tissues, he participated in epidemiological genotoxicity studies comprising populations occupationally exposed to various agents and studies aiming to define baseline level of genetic damage in general population. Genotoxicity assessments were mainly focused on effect of pesticides, mycotoxins, and dental materials. In 2017 he was recognized as European Registered Toxicologist (ERT) and certified. He has experience as a scientific and organizing committees’ member of 3 international and 4 domestic conferences, being a principal investigator of 2 domestic research projects, member of project proposals evaluation panels, member of the editorial board of the BioMed Research International and Toxics, guest editor of the special issue of the Water, expert at the European Chemicals Agency (ECHA), expert at the European Food Safety Authority (EFSA). He acted as the president of the Croatian branch of the EUROTOX's Register of certified toxicologists, certified as European Registered Toxicologist by Federation of European Toxicologists and European Societies of Toxicology EUROTOX, is a member of the Partner Experts Group for revision of the REACH regulation of European Commission in the field of mutagenicity/genotoxicity testing and endocrine disruption, member of the REACH Exposure Expert Group (REEG) of ECHA, member of the Croatian Toxicological Society, European Association for Cancer Research, European Cytogeneticists Association. Davor Zeljezic has published 126 peer-reviewed publications cited more than 2000 times by other authors, h-index 26.

Dr. Ian Martins is conferred with the Richard Kuhn Research Award-2015 Endocrinology and Metabolism. Dr. Ian James Martins is the Chief Editor of the International Journal of Diabetes Research and has joined the Editors of the Annals of Obesity and Disorders/International Journal of Diabetes Research and International Journal of Advances in Biology (2016). Reviewer for the Journal of Food Research/Annals of Neurodegenerative Disorders (2016) and previously for various other international journals. Research Gate’s analysis available on www.google.com.au under Ian James Martins of Dr. Martins’ publication stats place the Scientific reputation (RG score) higher than 96-97% of the international researchers with an H-index of 20 with 80 full-text publications. Contribution: Peripheral sink amyloid-beta clearance pathway with relevance to chronic disease and Alzheimer’s disease. Certificates of recognition at various international congress/conventions in various countries for invited speeches and keynote address (Ethnopharmacology 2016). Frontiers in Genetics places Ian James Martins outputs to be > 99% of all Loop authors. Research Online lists 37 ECU publications that are under Global analysis from Ian James Martins. Prestigious Recognition of Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). Certificates from various international conferences have been received in relation to anti-aging, health, and disease.

Dr. Mosad Zineldin is a Professor at Faculty of Health and Life Sciences-Medicine and Optometry institution. Linnaeus University- Sweden. Grounder of ACRC (Academic Center for Research and Consultancy) in Sweden, He have a multidisciplinary background in Health Science, Phycology,community health, Psychiatry, Medical and Quality studies. Taught at Stockholm University for many years. He is supervisor of degree projects for medical students. Had leading positions at Linnaeus and Stockholm universities in Sweden. Editor in Chief and Associate Editor of several Psychology and Psychiatry international Journals. Wrote and published several books and over 100 articles in many different international journals. He has invented new concepts, models and theories related to medical and health sciences. His latest major research interests and publications are on Cognitive and Bran Reserve Interventions to reduce the risk of Dementia; Preventive medicine and Divorce on Physical and Mental Health; Brain Arteriovenous Malformations (BAVMs) and Endovascular Catheter Embolization; e-health and digitalization of medical and health education.

Anas Bilal received a B.S. degree in telecommunication and networks from Iqra University, Pakistan, in 2013, an M.S. degree in electrical and electronic systems from the University of Lahore, Pakistan, in 2016, and a Ph.D. degree in Electronics science and technology from Beijing University of Technology, Beijing, China in 2021. He works as an assistant Professor and undergraduate supervisor at the Software College, Hainan Normal University, Haikou, China. He has published over50 technical articles in scientific journals and conference proceedings. His current research interests include AI, Computer vision, Image processing, medical imaging, Remote Sensing, and Pattern Recognition. Dr. Anas's research focuses on various image processing and computation communication methods through technology, developing new and innovative approaches for medical imaging and remote sensing images. Dr. Anas Bilal is an Academic Editor of PLOS ONE and CMC journal, Advisory Board Member of the Journal of Social Sciences Advancements, International Advisory Chair at BDAITM 2023, China, Programmed Chair at ICPPOE 2022, Programmed Chair at ICAICT 2023, and Member of the Technical Program Committee at AIIPCC 2023 and many more. He is a member of the Institute of Electrical and Electronics Engineering (IEEE), IEEE Computer Society Technical Community onComputer Architecture, and IEEE Young Professionals.

Willie Sai Ho Chan ( Prof Chan ) LLB, MD, grew up in Hong Kong. He completed his schooling from the Queen's College, Hong Kong, and studied aircraft engineering at the Hong Kong Far East Flying & Technical School. And he received his Bachelor's degree ( LLB ) from the China University of Political Science and Law in Beijing, China, and Doctor of Medicine ( MD ) from the China Medical University in Taiwan, China. He is currently working as Fellow, Professor and National Representative of the European Association for Predictive, Preventive and Personalised Medicine ( EPMA, Brussels, Belgium ) in Taiwan, China. He acts as Coordinator among other countries to promote the aim of the Association. He is an inter- and multi-disciplinar healthcare professional with increasing international recognition. He also serves as an Editor-in-Chief for several journals and is an editorial board member and reviewer for various journals. His main paper " Taiwan's Healthcare Report 2010 " ( EPMA Journal 20l0 ), was published in the book " Healthcare Overview " ( Springer 2012). Other selected papers : (1) " The Effect of Mortality of Diabetes Tubercosis Patients using Meta-Analysis, " Sports Injuries & Medicine, 2019; 3:150.1. (2) " Efficacy & Adverse Events of Fifth Generation Cephalosporin " Ceftaroline " in the Treatment of Community-Acquired Pneumonia : A Meta-Analysis," Clinical Medicine Pages, 2020; 1(1):3. (3) " Then and Now : Regenerative Medicine - A short Overview, " Archives of Health Science, 2022; 6(1):1-5. (4) " A New Hope : Regenerative Medicine, " Medical & Life Sciences, 2023; 2(2):30-46. (5) " The Blueprint of Traditional Chinese Medicine, "Archives of Health Science, 2023; 7(1):1-17. (6) " Uncover the Hidden Message in DNA, " Archives of Health Science, 2023; 7(1): 1-9. (7) " The DNA Phantom Effect in Medicine : Unraveling the Mysteries of Non-Physical DNA Interactions, " Universal Library of Medical & Health Sciences, 2023; 1(1): 65-73. (8) " The Role of Oral Health in the Prevention of Systemic Diseases, " Universal Library of Medical & Health Sciences, 2023; 1(1); 32-40. (9) " Encyclopedia of Epoch-Making of the Traditional Chinese Medicine in the Treatment of Coronaviruses, " Universal Library of Medical & Health Sciences, 2024; 2(1):01-21. His works is cited in many other journals and books. His work aims at driving forward research in the field of Chinese and Western medicine by providing high-quality evidence based papers for academics, experts, researchers, and other related health professionals. His prime research areas include Chinese and Westerm Medicine, quantum mechanics, genetics, nanomedicine, nanochemistry, cell biology, oncology, health sciences, DNA Phantom Effect.

Dr. Jiankang Liu received his BS from Xi’an JiaotongUnviersity and PhD of Medical Science from Okayama University School of Medicine, Japan. He completed post-doc training in Dr. Bruce Ames laboratory at University of California, Berkeley and worked as a faculty at University of California at Berkeley, Children Hospital Oakland Research Institute, University of California at Irvine, University of Kentucky College of Medicine, and University of Southern California. Currently, he is a Professor and Dean of the School of Life Sciences, University of Health and Rehabilitation Sciences at Qingdao and Xi’an Jiaotong University at Xi’an, China. Dr. Liu’s research interests include molecular and cellular mechanisms of aging, stress, and age-/stress-associated diseases with a focus on redox-mitochondrial metabolism and mitoepigenetics. He has published 280 papers with more than 19,000 times citations （H-index 78）and was elected as one of the Most Cited Chinese Researchers in the area of Biochemistry, Genetics and Molecular Biology by Elsevier consecutively for 10 years (2015-2024) and the World Top Scientists from 2019-2023.

Dr. Khue Vu Nguyen (born in Ha Noi, Viet Nam) is currently Visiting Professor in the School of Medical Imaging, Jiangsu Vocational College of Medicine, Yancheng 224005 Jiangsu, China, and collaborating for research work with the Centre for Molecular Biophysics from Centre National de la Recherche Scientifique, CNRS, at Orleans, 45071 Orleans, France. He was Full Project Scientist in the Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California 92103, U.S.A. He has worked as Scientist in different French and U.S. Research Institutions and Companies. He has studied at University Louis Pasteur, Strasbourg, France: B.S. in Biochemistry; M.S. in Molecular Biology; Ph.D. in Macromolecular Physical Chemistry; Ph.D. in Physical Sciences (Doctorat d’Etat es Sciences Physiques). He is author and co-author of numerous publications and holder of many patents. He is listed in Who’s Who in the World; Who’s Who in America; Who’s Who in Science and Engineering; Who’s Who in Medicine and Healthcare. He is member of different academic organizations such as American Society for Microbiology; American Chemical Society. He is Editor-in-Chief of different scientific journals such as Current Pediatric Research; Enliven: Journal of Genetics, Molecular and Cellular Biology; Journal of Brain Research; etc. He is Editorial Board Member of different scientific journals such as Metabolic Brain Disease; Journal of Pediatric Genetics; Expert Opinion on Orphan Drugs; etc. He is also Invited Reviewer of different scientific journals such as Molecular Genetics and Metabolism; AGE: Journal of the American Aging Association; Journal of Neural Transmission; etc. He is Scientist Reviewer for grant proposals of the Metabolic Disease Two (MB-2) of the Peer Review Medical Research Program (PRMRP) for the U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP). Current research includes genetic diseases, neurodevelopmental and neurodegenerative disorders, and cancer